Connect
← Return to Care Plans or Protocols
Discussion
Pancreatic Cancer | Last Active: Feb 25 11:50am | Replies (13)
Comment receiving replies
@mcharlesfrancis I have the KRAS G12D and TP53 mutations. I am glad you mentioned targeted options. I will add that to my list of questions this second meeting with my "new" oncologist. Thank you!
Replies to "@mcharlesfrancis I have the KRAS G12D and TP53 mutations. I am glad you mentioned targeted options...."
@199 My wife is on a new trial for another first in human KRAS targeted drug.
I have a background in clinical science and believe this new class of therapy and antibody drug conjugates (targeted chemo) are going to greatly improve outcomes over the next 3 to 5 years.
Just hoping my wife holds on long enough to benefit from these advances.
Connect
@199 there are medications on clinicals right now, very promising and I was told might be soon, company is Revolution Medicine. In my case I was told would not work for me mine is not metastatic and not KRAS.